Latest It Consulting News

Inventis Limited has agreed to sell its Electronic Circuit Designs division for A$2.4 million, while retaining an option to repurchase the business within a year. The move aims to reduce debt and streamline operations ahead of a planned technology-driven growth phase.

Wiseway Group Limited will seek retrospective shareholder approval for critical related party leases after ASX determines prior approvals were required. The company assures operations remain unaffected as it commissions an independent fairness report.

Canadian Phosphate Limited has obtained a 10,000-tonne bulk sample permit for its Barnes deposit at the Fernie Project, marking a significant step toward establishing a domestic phosphate supply in British Columbia. Additional permits are underway, supporting the company’s growth and critical minerals strategy.

Staude Capital Global Value Fund Limited (GVF) launches a Share Purchase Plan offering existing shareholders a chance to invest up to $30,000 at a price near its net asset value, following nearly five years without a capital raise.

Makilala Mining has appointed leading consultants to refine and optimise the MCB Copper-Gold Project’s mine plan and infrastructure design, aiming to enhance operational efficiency and environmental outcomes.

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.

Renascor Resources has received provisional development authorisation from South Australia’s Minister for Planning to build a commercial-scale battery anode material plant, marking a pivotal step in its vertically integrated graphite project.

Terra Metals has raised $4 million through a strategic placement, attracting heavyweight investors to accelerate exploration at its Dante Project in Western Australia.

Santana Minerals has announced a delay in submitting its Fast Track Approvals Application due to pending ecological consultant reports, missing the previously set June 30 deadline. The company remains optimistic about finalising the reports soon and prioritising the submission.

Tivan Limited has made significant progress on a revised access road for its Speewah Fluorite Project, balancing infrastructure needs with cultural heritage preservation. The company also secured key native title agreements and regulatory approvals supporting its feasibility study and joint venture with Sumitomo Corporation.

Challenger Limited has welcomed APRA’s consultation on new capital settings for annuity products, highlighting the potential for regulatory reforms to boost innovation and growth in Australia’s retirement income sector.

Island Pharmaceuticals has reported encouraging Phase 2a/b trial results for ISLA-101, demonstrating meaningful reductions in dengue viral load and symptoms in humans. The findings support further clinical development of this antiviral candidate.